Citation Impact
Citing Papers
Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study
2014
Catalytic enantiocontrol over a non-classical carbocation
2020 StandoutNobel
An efficient system for the evolution of aminoacyl-tRNA synthetase specificity
2002
PACKMOL : A package for building initial configurations for molecular dynamics simulations
2009 Standout
Synthesis of an insecticidal tetrahydroisocoumarin, (3R,4S,4aR)-4,8-dihydroxy-3-methyl-3,4,4a,5-tetrahydro-1H-2-benzopyran-1-one
2006
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Myeloid-derived suppressor cells coming of age
2018 Standout
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
2013
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor Stimulation
2002 StandoutNobel
Increased CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells Correlate With Disease Severity in Systemic Lupus Erythematosus Patients in an iNOS-Dependent Manner
2019
Neural mechanism underlying acupuncture analgesia
2008 Standout
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
The antisense homology box: A new motif within proteins that encodes biologically active peptides
1995 StandoutNobel
Thrombin receptor (PAR-1) antagonists. Solid-Phase synthesis of indole-Based peptide mimetics by anchoring to a secondary amide
2001
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Myelin basic protein‐dependent plasma membrane reorganization in the formation of myelin
2006 StandoutNobel
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis
2019
Incidence of low bioavailability of leuprolide acetate after percutaneous administration to rats by dissolving microneedles
2011
Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity
2006
Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
2018
Disulfide-rich macrocyclic peptides as templates in drug design
2014
Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis
2014
Ren1c Homozygous Null Mice Are Hypotensive and Polyuric, but Heterozygotes Are Indistinguishable from Wild-Type
2004 StandoutNobel
CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering
2007
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation
2015
β-Arrestin 2-Dependent Angiotensin II Type 1A Receptor-Mediated Pathway of Chemotaxis
2005 StandoutNobel
Intrinsically disordered proteins in cellular signalling and regulation
2014 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods
2002 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Important roles for angiotensin III and IV in the brain renin-angiotensin system
1997
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases
2016
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
2012 StandoutNatureNobel
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Catalytic Enantioselective Addition of Dialkylzinc Reagents to N‐Acylpyridinium Salts
2009 StandoutNobel
Elevated granulocytic myeloid-derived suppressor cells are closely related with elevation of Th17 cells in mice with experimental asthma
2020
Microneedles for drug and vaccine delivery
2012 Standout
Myelin basic protein—diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis
2004
Structure Determination and Total Synthesis of (+)‐16‐Hydroxy‐16,22‐dihydroapparicine
2013 StandoutNobel
Small molecule antagonists of proteins
2002
Molecular and cellular insights into T cell exhaustion
2015 Standout
Angiotensin ‘antipeptides’: (−)messenger RNA complementary to human angiotensin II (+)messenger RNA encodes an angiotensin receptor antagonist
1989
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Structural Basis for Thrombin Activation of a Protease-Activated Receptor
2003
APD3: the antimicrobial peptide database as a tool for research and education
2015 Standout
Phenotypic and functional alterations of myeloid‐derived suppressor cells during the disease course of multiple sclerosis
2018
Solid-Phase Synthesis of Carboxylic and Oxamic Acids via OsO4/NaIO4/HMTA-Mediated Oxidative Cleavage of Acetylenic Peptides
2007 StandoutNobel
Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure
2005
AT2-Selective Angiotensin II Analogues Containing Tyrosine-Functionalized 5,5-Bicyclic Thiazabicycloalkane Dipeptide Mimetics
2004
Simple and efficient syntheses of Boc- and Fmoc-protected 4(R)- and 4(S)-fluoroproline solely from 4(R)-hydroxyproline
2002
Solid-Phase Synthesis of an Oxalic Acid Amide Library
2004
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Azole-Based Energetic Salts
2011 Standout
Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure
2016
Synthesis of Pyridine and Dihydropyridine Derivatives by Regio- and Stereoselective Addition toN-Activated Pyridines
2012 Standout
Synthesis and Porous Properties of Chromium Azolate Porous Coordination Polymers
2014 StandoutNobel
Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung
2019
Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry
2013
Recent Advances in the Total Synthesis of Piperidine and Pyrrolidine Natural Alkaloids with Ring‐Closing Metathesis as a Key Step
2003
Increased GITRL Impairs the Function of Myeloid-Derived Suppressor Cells and Exacerbates Primary Sjögren Syndrome
2019
Elimination of Granulocytic Myeloid‐Derived Suppressor Cells in Lupus‐Prone Mice Linked to Reactive Oxygen Species–Dependent Extracellular Trap Formation
2015
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series
1994
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
2009 Standout
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Tofacitinib Facilitates the Expansion of Myeloid‐Derived Suppressor Cells and Ameliorates Arthritis in SKG Mice
2014
Promiscuity as a functional trait: intrinsically disordered regions as central players of interactomes
2013
Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses
2017
Myeloid‐derived suppressor cells: the dark knight or the joker in viral infections?
2013
Structural characterization of intrinsically disordered proteins by the combined use of NMR and SAXS
2012
MoRFpred, a computational tool for sequence-based prediction and characterization of short disorder-to-order transitioning binding regions in proteins
2012
A Macrocyclic Agouti-Related Protein/[Nle4,DPhe7]α-Melanocyte Stimulating Hormone Chimeric Scaffold Produces Subnanomolar Melanocortin Receptor Ligands
2017
Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses
2013
Photochemical Transformations of Tetrazole Derivatives: Applications in Organic Synthesis
2010
Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists
2017 StandoutNobel
Sunflower trypsin inhibitor (SFTI-1) analogues of synthetic and biological origin via N→S acyl transfer: potential inhibitors of human Kallikrein-5 (KLK5)
2014 StandoutNobel
Myeloid‐Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus
2016
Mechanism and Scope of Base‐Controlled Catalyst‐Free N‐Arylation of Amines with Unactivated Fluorobenzenes
2016 StandoutNobel
Small-Molecule H-Bond Donors in Asymmetric Catalysis
2007 Standout
Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling
2005 StandoutNobel
Molecular Dynamics Simulations of Angiotensin II in Aqueous and Dimethyl Sulfoxide Environments
2005
Asymmetric Allylic Alkylation in Combination with Ring-Closing Metathesis for the Preparation of Chiral N-Heterocycles
2010 StandoutNobel
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Natural Products as Sources of New Drugs over the Last 25 Years
2007 Standout
Mechanisms of Diabetic Complications
2013 Standout
Myeloid-Derived Suppressor Cells Contribute to Staphylococcus aureus Orthopedic Biofilm Infection
2014
Arginase-1–dependent promotion of T H 17 differentiation and disease progression by MDSCs in systemic lupus erythematosus
2016
Role of AT2receptor in the brain in regulation of blood pressure and water intake
2003
Update 1 of: Computational Modeling Approaches to Structure–Function Analysis of G Protein-Coupled Receptors
2011
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Stapled β-Hairpins Featuring 4-Mercaptoproline
2021 StandoutNobel
C−F Bond Activation in Organic Synthesis
2009
Direct release of nitriles from solid phase
2001
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis
2018 StandoutNobel
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
Highly Efficient Solid-Phase Oxidative Cleavage of Olefins by OsO4−NaIO4 in the Intramolecular N-Acyliminium Pictet−Spengler Reaction
2005 StandoutNobel
5‐Substituted 1H‐Tetrazoles as Carboxylic Acid Isosteres: Medicinal Chemistry and Synthetic Methods
2003 Standout
Works of John Matsoukas being referenced
Microwave-assisted solid-phase peptide synthesis of the 60–110 domain of human pleiotrophin on 2-chlorotrityl resin
2010
The design and synthesis of a potent angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone angiotensin II
2000
Effects of peptide and non-peptide antagonists of angiotensin II receptors on drinking behavior in rats
1999
The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception
2003
The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: A concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives
2012
Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-Chain bridges
2002
Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonists
2000
Recognition Pliability Is Coupled to Structural Heterogeneity: A Calmodulin Intrinsically Disordered Binding Region Complex
2012
In vivo evaluation and in vitro metabolism of leuprolide in mice—mass spectrometry‐based biomarker measurement for efficacy and toxicity
2008
Structure elucidation and conformational properties of eprosartan a non peptide Angiotensin II AT1 antagonist
2002
Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of π*–π* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT1 non-peptide antagonists
2001
An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT1 Angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies
2010
Round and Round we Go: Cyclic Peptides in Disease
2006
Synthesis and biological activities of angiotensin II, sarilesin, and sarmesin analogs containing Aze or Pip at position 7
1993
Importance of the N-terminal domain of the type II angiotensin antagonist sarmesin for receptor blockade
1988
I. 1H-NMR studies of [Sar1]angiotensin II conformation by nuclear Overhauser effect spectroscopy in the rotating frame (ROESY): Clustering of the aromatic rings in dimethylsulfoxide
1990
Differences in Backbone Structure between Angiotensin II Agonists and Type I Antagonists
1995
Animal Models of Central Nervous System Immune-Mediated Diseases: Therapeutic Interventions with Bioactive Peptides and Mimetics
2005
Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune Disease
2011
An Effort To Understand the Molecular Basis of Hypertension through the Study of Conformational Analysis of Losartan and Sarmesin Using a Combination of Nuclear Magnetic Resonance Spectroscopy and Theoretical Calculations
1999
A new approach to angiotensin antagonists: Methylation of the tyrosine hydroxyl in angiotensin II
1984
Synthesis and Contractile Activities of Cyclic Thrombin Receptor-Derived Peptide Analogues with a Phe-Leu-Leu-Arg Motif: Importance of the Phe/Arg Relative Conformation and the Primary Amino Group for Activity
1996
Design and Synthesis of a Potent Cyclic Analogue of the Myelin Basic Protein Epitope MBP72-85: Importance of the Ala81Carboxyl Group and of a Cyclic Conformation for Induction of Experimental Allergic Encephalomyelitis
1999
Design, Synthesis, and Modeling of Novel Cyclic Thrombin Receptor-Derived Peptide Analogues of the Ser42-Phe-Leu-Leu-Arg46 Motif Sequence with Fixed Conformations of Pharmacophoric Groups: Importance of a Phe/Arg/NH2 Cluster for Receptor Activation and Implications in the Design of Nonpeptide Thrombin Receptor Mimetics
2000
Synthesis and biological activities of analogs of angiotensins II and III containing O-methyltyrosine and D-tryptophan
1985
Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II.
1994
Antagonistic Effects of Human Cyclic MBP87-99Altered Peptide Ligands in Experimental Allergic Encephalomyelitis and Human T-Cell Proliferation
2001
Synthesis of d,l-epiramulosin and the configuration of ramulosin
1976
One pot synthesis and conformation of N-t-butyloxycarbonyl, O-Phenacyl derivatives of proline and other secondary amino acids
1990